Bank of Montreal
BIVV

Bank of Montreal’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Bank of Montreal’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-151,924
Closed -$8.19M – 4488
2017
Q4 		$8.19M Sell
151,924
-38,097
-20% -$2.08M 0.01% 930
2017
Q3 		$10.8M Buy
190,021
+173,312
+1,037% +$10.2M 0.01% 828
2017
Q2 		$1M Buy
16,709
+3,409
+26% +$194K ﹤0.01% 1976
2017
Q1 		$726K Buy
+13,300
New +$655K ﹤0.01% 1968

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Bank of Montreal's BIVV Position: Q1 2018 in Review

Bank of Montreal sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 151,924 shares — an estimated $8.19M sold.

Bank of Montreal first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $10.8M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Bank of Montreal reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Bank of Montreal sold 151,924 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $8.19M.
  • Bank of Montreal first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Bank of Montreal's Bioverativ Inc. Common Stock position peaked at $10.8M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Bank of Montreal's 13F filing for Q1 2018, filed 13 Apr 2018.